Fundraising Fox

GeneTx Biotherapeutics

Downers Grove, US · Founded 2017 · Delaware LLC

Biotech

Founders & leadership

AB
Allyson BerentExecutive
PE
Paula EvansNamed on SEC filing

Board

MH
Michael HanrahanBoard director

Reported raises · per SEC filings

Form D private placements

$6.3M disclosed across 1 round · 2018

▶$6.3MraisedApr 2019 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Allyson BerentExecutive Officer, Director
  • Paula EvansExecutive Officer, Director
  • Michael HanrahanDirector
Offering amount
$6.3M
Amount sold
$6.3M
First sale
Oct 2018
Incorporated
Limited Liability Company, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Further Understanding The FAST & GeneTx Relationship - FASTcureangelman.org · Feb 2021FAST Conference Draws 20 Pharmaceutical Companies And Raises Over $2.2 Million For Research - FASTcureangelman.org · Dec 2020GeneTx and Ultragenyx Announce Positive Interim Phase 1/2 Data on Investigational GTX-102 Demonstrating Improvement in Patients with Angelman Syndromeglobenewswire.com · Oct 2020GeneTx Biotherapeutics receives FDA orphan-drug designation for Angelman syndrome treatmentglobenewswire.com · Mar 2018

Frequently asked questions

How much funding has GeneTx Biotherapeutics raised?
GeneTx Biotherapeutics has disclosed $6.3M raised across 1 round.
Where is GeneTx Biotherapeutics headquartered?
GeneTx Biotherapeutics is headquartered in Downers Grove, US.